A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral Diclofenac

  • Garen Manvelian, Stephen Daniels, Allan Gibofsky
  • Pain Medicine, November 2012, Oxford University Press (OUP)
  • DOI: 10.1111/j.1526-4637.2012.01479.x

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/j.1526-4637.2012.01479.x